Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer

NCT01908478 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Veliparib
DRUG: Gemcitabine
RADIATION: Intensity modulated radiation therapy

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]